| scholarly article | Q13442814 |
| P50 | author | Jeffrey A Sparks | Q42371099 |
| Elizabeth W Karlson | Q98839527 | ||
| Florencia Halperin | Q117244498 | ||
| Bonnie L Bermas | Q117251095 | ||
| P2093 | author name string | Jonathan C Karlson | |
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| Adipokines in inflammation and metabolic disease | Q29620456 | ||
| Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice | Q33637603 | ||
| Overweight, obesity, and health risk | Q33890013 | ||
| The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis | Q34139272 | ||
| Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study | Q34392481 | ||
| American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. | Q34782898 | ||
| American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials | Q35047250 | ||
| The human gut microbiome: a review of the effect of obesity and surgically induced weight loss | Q35360260 | ||
| The microbiome and rheumatoid arthritis | Q35743863 | ||
| Obesity as a risk factor for osteoarthritis: mechanical versus metabolic. | Q35881569 | ||
| Sex differences in assessment of obesity in rheumatoid arthritis | Q36409526 | ||
| Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee | Q36823478 | ||
| Clinical pharmacokinetics and use of infliximab | Q36892770 | ||
| Smoking and overweight determine the likelihood of developing rheumatoid arthritis | Q37206595 | ||
| Non-drug therapies in early rheumatoid arthritis | Q37398097 | ||
| Adiposity and hand osteoarthritis: the Netherlands Epidemiology of Obesity study | Q37690274 | ||
| Obesity in rheumatoid arthritis | Q37801496 | ||
| Drug-free remission: is it already possible? | Q37856143 | ||
| Rheumatoid arthritis disease measurement: a new old idea | Q38065766 | ||
| Metabolic surgery for type 2 diabetes: efficacy and risks | Q38081043 | ||
| From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis? | Q38123798 | ||
| The epidemiology of osteoarthritis | Q38209060 | ||
| Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications | Q38428629 | ||
| Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study | Q43705272 | ||
| Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study | Q43991225 | ||
| Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus | Q44609117 | ||
| The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism | Q44992657 | ||
| Effect of body mass index on mortality and clinical status in rheumatoid arthritis | Q45158519 | ||
| Updated Bariatric Analysis and Reporting Outcome System (BAROS). | Q46151897 | ||
| Serum C-reactive protein and white blood cell count in morbidly obese surgical patients | Q46465988 | ||
| Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine | Q46479144 | ||
| CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects | Q46595366 | ||
| Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile | Q47202247 | ||
| Weight reduction in obese patients with rheumatoid arthritis, with preservation of body cell mass and improvement of physical fitness | Q47331965 | ||
| Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. | Q47885394 | ||
| The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. | Q50639396 | ||
| Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. | Q50925165 | ||
| Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. | Q51667223 | ||
| Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis | Q57224067 | ||
| Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator | Q57752094 | ||
| Association of High Body Mass Index With Decreased Treatment Response to Combination Therapy in Recent-Onset Rheumatoid Arthritis Patients | Q57788293 | ||
| A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis | Q58234922 | ||
| Obesity and Inflammation: Change in Adiponectin, C-Reactive Protein, Tumour Necrosis Factor-Alpha and Interleukin-6 After Bariatric Surgery | Q62090496 | ||
| Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate | Q70406496 | ||
| Reporting Results in Obesity Surgery: Evaluation of a Limited Survey | Q73576811 | ||
| Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis | Q79882239 | ||
| Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index | Q81517338 | ||
| Body mass index and clinical response to infliximab in rheumatoid arthritis | Q83328142 | ||
| Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA | Q87370747 | ||
| P433 | issue | 12 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| bariatric surgery | Q357503 | ||
| P304 | page(s) | 1619-1626 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis | |
| P478 | volume | 67 |
| Q100385853 | Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies |
| Q55563232 | Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data. |
| Q64105890 | Consequences of bariatric surgery on outcomes in rheumatic diseases |
| Q55220546 | Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation? |
| Q88386933 | High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis |
| Q92324796 | Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases |
| Q90267503 | Nutrition Interventions in Rheumatoid Arthritis: The Potential Use of Plant-Based Diets. A Review |
| Q54940383 | Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. |
| Q87962122 | Rheumatoid arthritis: Disconnect in the effects of obesity on RA outcomes |
| Q90397063 | The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition |
| Q89819053 | The outcomes of bariatric surgery on rheumatoid arthritis disease activity: a prospective cohort study |
| Q56968449 | [S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs] |
Search more.